Get the Stockscreener App
0.863
5.12%
0.042
After Hours:
.86
-0.003
-0.35%
Intercure Ltd stock is traded at $0.863, with a volume of 16,556.
It is up +5.12% in the last 24 hours and up +13.55% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
See More
Previous Close:
$0.821
Open:
$0.8435
24h Volume:
16,556
Relative Volume:
0.39
Market Cap:
$47.19M
Revenue:
$117.93M
Net Income/Loss:
$5.00M
P/E Ratio:
6.5677
EPS:
0.1314
Net Cash Flow:
$-12.91M
1W Performance:
-0.43%
1M Performance:
+13.55%
6M Performance:
-37.13%
1Y Performance:
-45.72%
1-Day Range:
$0.8435
$0.8941
1-Week Range:
$0.77
$0.8941
52-Week Range:
$0.68
$1.7698
Intercure Ltd Stock (INCR) Company Profile
Compare INCR vs TAK, ZTS, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.863 | 44.89M | 117.93M | 5.00M | -12.91M | 0.1314 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
InterCure Posts 2025 Revenue Growth, Positive Cash Flow as Recovery and Expansion Accelerate - TipRanks
InterCure (NASDAQ: INCR) grows 2025 revenue to NIS 270M with positive cash flow - Stock Titan
InterCure Ltd. Reports NIS 270 Million Revenue and Positive Cash Flow for 2025 Amid Recovery Efforts - Quiver Quantitative
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow - Weekly Voice
Intercure LTD (INCR) Releases Q4 2025 Earnings: Revenue Up 43.8% but Company Remains Unprofitable - Quiver Quantitative
InterCure (INCR) 2025 20-F outlines licensing, war and market risks - Stock Titan
InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Intercure (INCR) director discloses shares and stock options - Stock Titan
Intercure (INCR) director reports 15,000 share options at $3.10 strike - Stock Titan
Intercure (INCR) CEO details major share, warrant and option holdings - Stock Titan
David Salton Net Worth (2026) - GuruFocus
Amos Cohen Net Worth (2026) - GuruFocus
Gideon Hirschfeld Net Worth (2026) - GuruFocus
Intercure (INCR) CFO discloses option grants and share stake - Stock Titan
Intercure (INCR) director Gideon Hirschfeld reports existing stock option grants - Stock Titan
Intercure (INCR) director David Salton reports option positions in Form 3 - Stock Titan
Intercure (INCR) Stock: Portfolio Addition? (Selling Pressure) 2026-04-15Elite Trading Signals - Newser
Investment Report: Whats the fair value of InterCure Ltd stockRisk Management & Consistent Growth Stock Picks - baoquankhu1.vn
Aug Levels: Is InterCure Ltd being accumulated by smart moneyExit Point & Weekly Breakout Stock Alerts - baoquankhu1.vn
Analyst Calls: How volatile is InterCure Ltd stock2026 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
INCR PE Ratio & Valuation, Is INCR Overvalued - Intellectia AI
INCR Price Today: Intercure Ltd. Stock Price, Quote & Chart - MEXC Exchange
Stock Report: Is InterCure Ltd a potential multi bagger2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
Aug Update: Should I invest in InterCure Ltd before earnings2026 Top Decliners & Fast Moving Trade Plans - baoquankhu1.vn
INCR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Highs Report: Why is InterCure Ltd stock going up2026 Performance Recap & Weekly Setup with High ROI Potential - baoquankhu1.vn
Stock Analysis: Is InterCure Ltd being accumulated by smart money2026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
Aug Highlights: What are analysts price targets for InterCure LtdTreasury Yields & Accurate Intraday Trade Tips - baoquankhu1.vn
Intercure (INCR) Stock Analysis Report | Financials & Insights - Benzinga Japan
Market Fear: Is HCAT stock forming a triangle patternProduct Launch & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Will InterCure Ltd. stock split again soon2025 Analyst Calls & Daily Entry Point Trade Alerts - Naître et grandir
Aug Analyst Calls: Is InterCure Ltd a potential multi baggerWeekly Trade Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
INCR Earnings History & Surprises | EPS & Revenue Results | INTERCURE LTD (NASDAQ:INCR) - chartmill.com
INCR,UMBF Revenue Breakdown - Finviz
InterCure Faces Nasdaq Compliance Deadline After Bid-Price Breach - The Globe and Mail
InterCure receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Canada
InterCure receives Nasdaq notice for minimum bid price deficiency - Investing.com South Africa
InterCure Receives Noncompliance Notice From Nasdaq - marketscreener.com
InterCure receives Nasdaq notification regarding minimum bid requirement - marketscreener.com
Nasdaq warns InterCure (Nasdaq: INCR) on sub-$1 share price and listing - Stock Titan
InterCure Ltd. Receives Nasdaq Compliance Notice Due to Bid Price Deficiency, Plans to Regain Compliance - Quiver Quantitative
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement - GlobeNewswire
InterCure weighs reverse share split after Nasdaq warns on sub-$1 stock price - Stock Titan
INCR Technical Analysis & Stock Price Forecast - Intellectia AI
Earnings Recap: Will RDACU outperform its industry peersJuly 2025 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
What’s the fair value of InterCure Ltd. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans - The Globe and Mail
Bearish Setup: Is InterCure Ltd being accumulated by smart money2025 Market Overview & Safe Capital Preservation Plans - baoquankhu1.vn
InterCure reports 11% revenue growth for 2025, enters German market By Investing.com - Investing.com Nigeria
InterCure reports 11% revenue growth for 2025, enters German market - Investing.com
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - markets.businessinsider.com
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):